SCHEMBL1492866

SCHEMBL1492866

COc1cc(OC)c(NC(=O)Nc2ccc(-c3ccnc(C)c3)cc2)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
MAPT P10636 3/20 0.61
PSEN1 P49768 4/20 0.54
PSEN2 P49810 4/20 0.54
APH1B Q8WW43 4/20 0.54
NCSTN Q92542 4/20 0.54
APH1A Q96BI3 4/20 0.54
PSENEN Q9NZ42 4/20 0.54
CHEK1 O14757 2/20 0.54
CHRNA7 P36544 1/20 0.52
IDH1 O75874 1/20 0.51
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
PORCN Q9H237 1/20 0.48
NTRK1 P04629 2/20 0.48
NTRK2 Q16620 2/20 0.48
TP53 P04637 1/20 0.47
IDO1 P14902 1/20 0.47
CNR1 P21554 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27809664 0.88 GRM4 (0.57) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492788 0.88 HTR2C (0.57) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL27809799 0.87 PSEN1 (0.54) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1493084 0.87 MEN1 (0.58) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492820 0.84 MAPT (0.65) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492687 0.83 PORCN (0.60) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492989 0.83 SMN1; SMN2 (0.62) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492881 0.83 PSEN1 (0.56) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492835 0.83 PSEN1 (0.57) MEN1KMT2AMAPTPSEN1PSEN2
SCHEMBL1492785 0.81 PSEN1 (0.57) MEN1KMT2AMAPTPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 MEN1 3122/4885KMT2A 3895/4885MAPT 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.